botulinum toxin vaccine (Molecular Targeting Technologies)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebotulinum toxin vaccine (Molecular Targeting Technologies)
Drug Alias Namerecombinant rabies virus expressing chimeric BoNT/A HC50 (Molecular Targeting Technologies)trivalent botulinum toxin vaccine (Molecular Targeting Technologies/Inventox)
ClassificationVaccines > Development/production technology > Inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Toxoid vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsBotulism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Targeting Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInventox LLCMolecular Targeting Technologies Inc
Active IndicationsN/A
Inactive IndicationsBotulism

Other Information

ATC CodeN/A
Related LinksN/A